SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

Registration Statements
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
EFFECT

EFFECT

Other
View HTML
CORRESP

CORRESP

Other
View HTML
CORRESP

CORRESP

Other
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe